670 related articles for article (PubMed ID: 24973821)
1. The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells.
Marçais A; Cherfils-Vicini J; Viant C; Degouve S; Viel S; Fenis A; Rabilloud J; Mayol K; Tavares A; Bienvenu J; Gangloff YG; Gilson E; Vivier E; Walzer T
Nat Immunol; 2014 Aug; 15(8):749-757. PubMed ID: 24973821
[TBL] [Abstract][Full Text] [Related]
2. TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway.
Viel S; Marçais A; Guimaraes FS; Loftus R; Rabilloud J; Grau M; Degouve S; Djebali S; Sanlaville A; Charrier E; Bienvenu J; Marie JC; Caux C; Marvel J; Town L; Huntington ND; Bartholin L; Finlay D; Smyth MJ; Walzer T
Sci Signal; 2016 Feb; 9(415):ra19. PubMed ID: 26884601
[TBL] [Abstract][Full Text] [Related]
3. The kinase mTOR modulates the antibody response to provide cross-protective immunity to lethal infection with influenza virus.
Keating R; Hertz T; Wehenkel M; Harris TL; Edwards BA; McClaren JL; Brown SA; Surman S; Wilson ZS; Bradley P; Hurwitz J; Chi H; Doherty PC; Thomas PG; McGargill MA
Nat Immunol; 2013 Dec; 14(12):1266-76. PubMed ID: 24141387
[TBL] [Abstract][Full Text] [Related]
4. Beneficial metabolic effects of rapamycin are associated with enhanced regulatory cells in diet-induced obese mice.
Makki K; Taront S; Molendi-Coste O; Bouchaert E; Neve B; Eury E; Lobbens S; Labalette M; Duez H; Staels B; Dombrowicz D; Froguel P; Wolowczuk I
PLoS One; 2014; 9(4):e92684. PubMed ID: 24710396
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus generates long-lived antigen-specific NK cells with diminished bystander activation to heterologous infection.
Min-Oo G; Lanier LL
J Exp Med; 2014 Dec; 211(13):2669-80. PubMed ID: 25422494
[TBL] [Abstract][Full Text] [Related]
6. Crosstalks between mTORC1 and mTORC2 variagate cytokine signaling to control NK maturation and effector function.
Wang F; Meng M; Mo B; Yang Y; Ji Y; Huang P; Lai W; Pan X; You T; Luo H; Guan X; Deng Y; Yuan S; Chu J; Namaka M; Hughes T; Ye L; Yu J; Li X; Deng Y
Nat Commun; 2018 Nov; 9(1):4874. PubMed ID: 30451838
[TBL] [Abstract][Full Text] [Related]
7. Repression of Mammalian Target of Rapamycin Complex 1 Inhibits Intestinal Regeneration in Acute Inflammatory Bowel Disease Models.
Guan Y; Zhang L; Li X; Zhang X; Liu S; Gao N; Li L; Gao G; Wei G; Chen Z; Zheng Y; Ma X; Siwko S; Chen JL; Liu M; Li D
J Immunol; 2015 Jul; 195(1):339-46. PubMed ID: 26026060
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic Target of Rapamycin Complex 1/S6 Kinase 1 Signals Influence T Cell Activation Independently of Ribosomal Protein S6 Phosphorylation.
Salmond RJ; Brownlie RJ; Meyuhas O; Zamoyska R
J Immunol; 2015 Nov; 195(10):4615-22. PubMed ID: 26453749
[TBL] [Abstract][Full Text] [Related]
9. Cutting edge: IL-15-independent NK cell response to mouse cytomegalovirus infection.
Sun JC; Ma A; Lanier LL
J Immunol; 2009 Sep; 183(5):2911-4. PubMed ID: 19648279
[TBL] [Abstract][Full Text] [Related]
10. IL-2 increases human telomerase reverse transcriptase activity transcriptionally and posttranslationally through phosphatidylinositol 3'-kinase/Akt, heat shock protein 90, and mammalian target of rapamycin in transformed NK cells.
Kawauchi K; Ihjima K; Yamada O
J Immunol; 2005 May; 174(9):5261-9. PubMed ID: 15843522
[TBL] [Abstract][Full Text] [Related]
11. Ly49H engagement compensates for the absence of type I interferon signaling in stimulating NK cell proliferation during murine cytomegalovirus infection.
Geurs TL; Zhao YM; Hill EB; French AR
J Immunol; 2009 Nov; 183(9):5830-6. PubMed ID: 19828630
[TBL] [Abstract][Full Text] [Related]
12. mTOR Complex Signaling through the SEMA4A-Plexin B2 Axis Is Required for Optimal Activation and Differentiation of CD8+ T Cells.
Ito D; Nojima S; Nishide M; Okuno T; Takamatsu H; Kang S; Kimura T; Yoshida Y; Morimoto K; Maeda Y; Hosokawa T; Toyofuku T; Ohshima J; Kamimura D; Yamamoto M; Murakami M; Morii E; Rakugi H; Isaka Y; Kumanogoh A
J Immunol; 2015 Aug; 195(3):934-43. PubMed ID: 26116513
[TBL] [Abstract][Full Text] [Related]
13. Differential controls of MAIT cell effector polarization by mTORC1/mTORC2 via integrating cytokine and costimulatory signals.
Tao H; Pan Y; Chu S; Li L; Xie J; Wang P; Zhang S; Reddy S; Sleasman JW; Zhong XP
Nat Commun; 2021 Apr; 12(1):2029. PubMed ID: 33795689
[TBL] [Abstract][Full Text] [Related]
14. Genetic and pharmacologic evidence that mTOR targeting outweighs mTORC1 inhibition as an antimyeloma strategy.
Chen X; Díaz-Rodríguez E; Ocio EM; Paiva B; Mortensen DS; Lopez-Girona A; Chopra R; Miguel JS; Pandiella A
Mol Cancer Ther; 2014 Feb; 13(2):504-16. PubMed ID: 24431075
[TBL] [Abstract][Full Text] [Related]
15. mTOR: a gate to NK cell maturation and activation.
Marçais A; Walzer T
Cell Cycle; 2014; 13(21):3315-6. PubMed ID: 25485573
[No Abstract] [Full Text] [Related]
16. IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells.
Mao Y; van Hoef V; Zhang X; Wennerberg E; Lorent J; Witt K; Masvidal L; Liang S; Murray S; Larsson O; Kiessling R; Lundqvist A
Blood; 2016 Sep; 128(11):1475-89. PubMed ID: 27465917
[TBL] [Abstract][Full Text] [Related]
17. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
[TBL] [Abstract][Full Text] [Related]
18. Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection.
Nguyen KB; Salazar-Mather TP; Dalod MY; Van Deusen JB; Wei XQ; Liew FY; Caligiuri MA; Durbin JE; Biron CA
J Immunol; 2002 Oct; 169(8):4279-87. PubMed ID: 12370359
[TBL] [Abstract][Full Text] [Related]
19. Natural killer group 2D and CD28 receptors differentially activate mammalian/mechanistic target of rapamycin to alter murine effector CD8+ T-cell differentiation.
McQueen B; Trace K; Whitman E; Bedsworth T; Barber A
Immunology; 2016 Mar; 147(3):305-20. PubMed ID: 26661515
[TBL] [Abstract][Full Text] [Related]
20. Continuous treatment with IL-15 exhausts human NK cells via a metabolic defect.
Felices M; Lenvik AJ; McElmurry R; Chu S; Hinderlie P; Bendzick L; Geller MA; Tolar J; Blazar BR; Miller JS
JCI Insight; 2018 Feb; 3(3):. PubMed ID: 29415897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
